FLNA

FILANA THERAPEUTICS, INC.

Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001069530 Biotech & Drug Discovery

$0.6400 −0.01 (−1.54%)

Oct 23 4:00 PM ET · prev $0.6500

Market cap

$31.6M

Nano cap

Median target

$6.50

+916% · range $5.00–8.00

Next earnings

Nov 11

in 16 days · EPS est. −$0.24

1 year

−83.2%

from $3.80 · Oct 27

30 days

−24.7%

from $0.8500

52-week range

$0.6400–3.80

at the low

Avg volume 20D

742.0K

Oct 1 spike 2.80M

Short interest

🔒 Subscribers only

Insider net

+$356.3K

1 buyer · 0 sellers · 12 mo

New fund stakes

Q2 2026 13F · 0 exits

Filing reports

analyzed by SecBot

SecBot read BULLISH 4 reports · 90 days

Balance 1 bearish · 2 bullish · 1 neutral oldest → newest, height = score

Avg score

·High conf. 4/4 ·Next Earnings date, Nov 11, 2026

Strongest BULLISH Filana Therapeutics announced that the Fifth Circuit vacated the district court's class certification order…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

R Mar 12 Filana Therapeutics reported a significantly wider net loss of $91.0…
R May 7 Filana Therapeutics (FLNA) reported Q1 2026 results with a net loss…
R Sep 18 Filana Therapeutics received a Nasdaq deficiency notice on September…
R Sep 22 Filana Therapeutics announced that the FDA has lifted the full clini…
E Sep 22 Trading halt: Trading Halt: FLNA — T1 (News Pending)
E Sep 22 Trading halt: Halt Resumed: FLNA — trading resumed after LUDP (Volatilit…
E Sep 22 Trading halt: Trading Halt: FLNA — LUDP (Volatility Trading Pause)
B Sep 28 to Sep 30 3 days of insider buys: $356.3K by 1 insider, avg $0.8910

Signal stack

Where each data set points today.

InsidersBULLISH

1 insider bought $356.3K at an average $0.8910. No open-market sales. Price is 28% below their cost.
InstitutionsBEARISH

Q2 2026: 7 added (0 new), 11 trimmed or exited.
EstimatesRISING

Current-quarter EPS estimate −$0.250 → −$0.245 over 90 days. 1 up, 1 down in 30 days.
TrendDOWNTREND

22% below its 50-day average. New closing low $0.6400 on Oct 23.
SocialQUIET

No Reddit mentions this week. Last mention Sep 28.

Who's buying

13F· Q2 2026

new positions

exits

Fund	Move	Shares	Value
ROYAL BANK OF CANADA	NEAR_EXIT	314	—
GOLDMAN SACHS GROUP INC	DOUBLED	668,792	$795.9K
SUSQUEHANNA INTERNATIONAL GROUP, LLP	TRIM	292,017	$347.5K
SIMPLEX TRADING, LLC	TRIM	99,879	$118.9K
JANE STREET GROUP, LLC	TRIM	58,981	$70.2K
PRICE T ROWE ASSOCIATES INC /MD/	ADD	40,860	$49.0K
UBS Group AG	DOUBLED	39,062	$46.5K
NewEdge Advisors, LLC	DOUBLED	28,300	$33.7K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Oct 2025

12-month targets · 2 analysts

$0.6400 $5.00 $6.50 $8.00

Price is below the lowest target. Median implies +916%.Targets as of Oct 27, 2026.

Recent actions

Date	Firm	Action	Rating
Oct 6, 2025	LUCID CAPITAL MARKETS INITIATE	INITIATE	Buy

Insider ledger

Form 4

$356.3K

bought · 1 insider

sold · 0 insiders

−28.2%

vs their $0.8910 cost

Date	Insider	Type	Value
Sep 30, 2026	Barry Richard President & CEO	BUY	$92.0K
Sep 29, 2026	Barry Richard President & CEO	BUY	$186.1K
Sep 28, 2026	Barry Richard President & CEO	BUY	$78.2K

Earnings setup

Estimates

Nov 11

reports in 16 days

−$0.24

EPS estimate, this quarter

+2%

estimate change, 90 days

1↑ 1↓

revisions, 30 days

Current-quarter EPS estimate

−$0.250

90d

−$0.250

60d

−$0.245

30d

−$0.245

Now

Period	EPS est.	Range	30D rev.	Revenue
Current Q	-$0.24	-$0.25–-$0.24	+0.0%	$0.00
Next Q	-$0.27	-$0.27–-$0.26	+0.0%	$0.00
Current FY	-$0.90	-$0.92–-$0.87	+0.0%	$0.00
Next FY	-$1.19	-$1.19–-$1.19	+0.0%	$0.00